Qualified Opportunity Zone Investing for Orthopedic Surgeons

When an orthopedic surgeon sells a private practice for $8 million, exits an ASC partnership, or sells appreciated real estate, the combined federal capital gains rate is 23.8% — 20% long-term capital gains plus the 3.8% Net Investment Income Tax. On an $8M gain, that's $1.9 million due to the IRS.

Qualified Opportunity Zones (QOZs) are the one mechanism that can defer that entire tax bill — and, if you hold long enough, eliminate the tax on any gains earned inside the fund entirely. The program was made permanent by the One Big Beautiful Bill Act (OBBBA) in July 2025, which also created a revised "OZ 2.0" structure starting in 2027 that is meaningfully better than the original.

This guide covers when QOZ investing makes sense for orthopedic surgeons, the OZ 1.0 vs OZ 2.0 rule differences, how the 180-day clock works for practice and ASC sales, and what to verify before committing capital to a Qualified Opportunity Fund.

Why orthopedic surgeons are ideal QOZ candidates

QOZ investing requires a realized capital gain to defer — the bigger the gain and the longer your investment horizon, the more the math works in your favor. Orthopedic surgeons often have both:

• Practice sales. Private practice buyouts at 6–12x EBITDA routinely generate $3M–$15M in capital gains. A spine surgeon selling a $1.2M-EBITDA practice at 9x with a stock sale structure has a $10.8M gain, producing $2.6M in federal tax at 23.8%.
• ASC equity exits. Surgeons selling their ASC partnership interest at a market transaction multiple ($500K–$3M typical for a partial exit) generate a lump-sum LTCG from what has often been held for 10+ years at very low basis.
• Long investment horizon. An orthopedic surgeon at 45–55 selling a practice has 10–25 years before they'd typically need liquidity from a QOF investment. That time horizon is exactly what the OZ structure rewards.
• High marginal rate. At $700K–$1.5M annual income, you are firmly in the 23.8% LTCG bracket. The tax deferred has high present value. Every dollar deferred today is worth more to you than to a taxpayer in a lower bracket.

OZ 1.0 vs OZ 2.0: two different rules depending on when you invest

The OBBBA created a two-tier system. Which rules apply to you depends on when you make your QOF investment — not when you recognized the underlying gain.

OZ 1.0 — investments made through December 31, 2026

If you invest deferred gain into a Qualified Opportunity Fund by December 31, 2026, the original TCJA rules apply:

• 180-day reinvestment window. You have 180 days from the date you recognize the gain to roll into a QOF. (See below for exceptions.)
• December 31, 2026 recognition deadline. All gains deferred under OZ 1.0 must be recognized and taxed by December 31, 2026, regardless of whether you've sold the QOF. Tax is due April 15, 2027.
• 5-year hold: 10% basis step-up. Your deferred gain is reduced by 10%, so you pay tax on only 90% of the original amount.
• 7-year hold: 15% basis step-up. An additional 5% exclusion — you pay on only 85% of the original gain.
• 10-year hold: exclude all QOF appreciation. The original deferred gain is still taxable (with the step-up), but any appreciation inside the QOF is permanently excluded from tax.

OZ 2.0 — investments made January 1, 2027 and later

The OBBBA's "OZ 2.0" program is substantially more attractive for new investors. It replaces the fixed December 31, 2026 deadline with a rolling schedule:

• Rolling 5-year deferral. Gains invested in a QOF in 2027 or later are deferred for 5 full years from the investment date — not until any fixed calendar deadline. Invest in March 2027, and the deferred gain isn't recognized until March 2032.
• 5-year hold: 10% basis step-up. Same 10% exclusion as OZ 1.0 at year 5. (The additional 5% step-up at year 7 is eliminated under OZ 2.0.)
• Rural Opportunity Zones: 30% step-up at 5 years. Investments in designated rural QOZ areas qualify for a 30% basis step-up instead of 10% — a significant enhancement for rural-focused QOFs.
• 10-year hold: all QOF appreciation excluded. Same exclusion of appreciation as OZ 1.0 — tax basis is stepped up to fair market value at time of sale, so all growth inside the fund is tax-free.
• 30-year hold: automatic FMV step-up. New in OZ 2.0: even without a sale, you get an automatic step-up in basis to fair market value at the 30-year mark.
• Program is now permanent. No sunset date. Future gains from practice sales, ASC exits, or any other LTCG event can always be invested into QOFs under OZ 2.0 going forward.

The 2026–2027 transition window for practice sellers

The transition between OZ 1.0 and OZ 2.0 creates an important planning detail for orthopedic surgeons selling practices or ASC interests in 2026.

The critical rule: which set of rules applies depends on when you invest in the QOF, not when you recognize the gain. The 180-day investment window starts from your gain recognition date. If that 180-day window spans December 31, 2026 / January 1, 2027, you can choose whether to invest under OZ 1.0 or OZ 2.0 rules.

Example: an orthopedic surgeon closes a practice sale on August 15, 2026, recognizing a $6M long-term capital gain. Their 180-day window runs through February 11, 2027. If they invest in the QOF in January 2027, they fall under OZ 2.0 rules — getting a rolling 5-year deferral (to January 2032) instead of the December 31, 2026 deadline that would apply to a 2026 investment. In most cases, a surgeon in this window is better off waiting until January 2027 to invest.

What qualifies as gain that can be invested

Not all capital gains qualify for QOZ deferral. The gain must be a recognized capital gain — long-term or short-term — from any source, including:

• Sale of a medical practice (stock or asset sale structure)
• Sale of ASC equity or partnership interest
• Sale of appreciated real estate (including office buildings or MOBs)
• Sale of publicly traded securities, RSUs, or other investments
• Section 1231 gains from business asset sales (treated as capital gain)

Ordinary income — including wRVU compensation, W-2 wages, and distributions from S Corps or partnerships that represent compensation — does not qualify. Neither do installment sale payments received in years after the initial gain recognition.

What a Qualified Opportunity Fund actually invests in

A QOF is a corporation or partnership that invests at least 90% of its assets in Qualified Opportunity Zone property — typically real estate development projects or operating businesses physically located in designated census tracts.

Common QOF structures:

• Real estate development. The most common structure. QOFs invest in new construction or substantial improvement of commercial, industrial, or residential properties in OZ census tracts. Typical holding period 7–12 years. Returns driven by development execution and exit cap rates.
• Operating businesses. QOFs can invest in business entities operating in OZ areas. Less common but possible for physician investors interested in healthcare-adjacent businesses in qualifying areas.
• Diversified multi-asset QOFs. Larger fund managers (Fundrise Opportunity Zone, CIM Group, Caliber, etc.) run multi-property diversified QOFs that give investors exposure across several projects in a single fund.

Most orthopedic surgeons access QOZ investing through third-party QOF managers rather than creating their own fund. The due diligence on a QOF manager is similar to any private real estate investment — but with the added requirement that the fund structure remain QOF-compliant for your entire holding period.

Evaluating a QOF: what to verify

Not all QOFs are equal. Before committing deferred capital gains, verify:

• Manager track record. What projects has this sponsor completed? What were actual investor returns vs. projected? QOF investing is relatively new (TCJA 2017); sponsors with longer track records in the underlying asset class matter more than QOZ-specific history.
• Fund structure and fees. Most QOFs charge a management fee (1–2% of AUM) plus a carried interest / promote (15–20% of profits above a preferred return). The fee load must be weighed against the tax benefit; a poorly structured fund can consume most of the tax savings.
• The 90% asset test mechanics. A QOF must maintain 90% of its assets in OZ property, tested semi-annually. Funds that violate this test lose QOF status and investors lose their deferral. Ask how the fund manages the test during construction periods.
• Exit mechanism. Since you need to hold 10 years for maximum benefit, the fund must have a plan to generate liquidity at year 10+. Real estate QOFs typically plan for a sale or refinance at exit. Confirm the expected exit strategy and that it aligns with your holding-period target.
• Liquidity restrictions. QOF investments are generally illiquid private placements with no secondary market. The tax benefit disappears if you sell before 10 years, so make sure the capital invested is not capital you may need for other purposes (ASC buy-in, malpractice tail, child education).
• UBTI risk in tax-exempt retirement accounts. QOF investments can generate Unrelated Business Taxable Income (UBTI) in certain structures. Do not invest IRA or 401(k) assets in a QOF that may trigger UBTI; the tax benefit belongs in your taxable brokerage account only.

QOZ vs other tax deferral / reduction strategies

For a large practice or ASC sale, QOZ is one of several tools. Compare it against alternatives before deciding how to deploy proceeds:

For most orthopedic surgeons, QOZ and installment sale are the primary choices. 1031 doesn't apply to practice or ASC sales. QSBS requires C-Corp structure that most practices don't use. DAF is charitable, not tax-deferral.

QOZ gain deferral calculator

Common mistakes orthopedic surgeons make with QOZ investing

• Missing the 180-day window. The clock starts at gain recognition. On a December practice closing, you have until late May to invest. Surgeons who procrastinate or wait for the right fund can find the window closed.
• Investing retirement account assets. QOZ deferral only applies to gains recognized in taxable accounts. Investing IRA or 401(k) assets in a QOF wastes a tax-sheltered account's existing benefits and may generate UBTI.
• Investing money you'll need within 10 years. QOF investment requires a 10-year commitment for the maximum tax benefit. Surgeons planning to retire in 7 years, fund a child's medical school, or make a large ASC buy-in shouldn't lock up proceeds in a QOF.
• Ignoring the December 31, 2026 phantom income event for existing OZ 1.0 investments. If you invested in a QOF in 2018–2021, your deferred gain is recognized on December 31, 2026 and taxed in your 2026 return. This may push your 2026 taxable income significantly higher, potentially triggering IRMAA lookback for 2028 Medicare premiums and compressing QBI deductions.
• Treating QOZ as a guaranteed profit strategy. The tax benefit is real, but the underlying investment still has to perform. A QOF that loses 30% of its value has destroyed more capital than the tax deferral saved. Evaluate the real estate fundamentals, not just the tax wrapper.

What a financial advisor does in a QOZ transaction

A fee-only advisor who works with orthopedic surgeons and has QOZ experience can:

• Model the exact tax liability of your practice or ASC sale and identify the optimal QOF investment amount (you don't have to roll the entire gain — rolling a portion may be optimal depending on liquidity needs)
• Calculate whether your 180-day window spans the OZ 1.0 / OZ 2.0 transition — and whether waiting to invest in January 2027 is worthwhile
• Evaluate competing QOF offerings on a risk-adjusted after-fee basis, not just on advertised return projections
• Coordinate the QOZ investment with estate planning (QOF interests can be gifted to irrevocable trusts with significant complexity), Roth conversion windows, and IRMAA planning
• Handle the phantom income event for existing OZ 1.0 investors in 2026 — including tax projection, cash reserve planning, and 2028 IRMAA mitigation